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 Aquaculture production has greatly increased over the past few decades, and will 
continue to grow as the world fisheries become overfished and demand for seafood increases. 
With increased production comes more intense cultivation methods and heavy use of formulated 
feeds that may contain veterinary drug residues. Currently no antibiotics are allowed in the U.S. 
for crawfish aquaculture; yet, detectable levels of various antibiotics have been found in 
imported seafood samples. The FDA is responsible for testing aquaculture products entering the 
United States, but only has the capabilities to test a minimal amount of those imports. 
Additionally, for crawfish there is only one published FDA method to test for chloramphenicol, 
and they have yet to publish a method to test for multiple veterinary drug residues. Therefore, the 
objective of this study was to develop a method that could test various antibiotics in 
commercially available frozen crawfish, and use that method to test imported and domestic 
crawfish.  
Crawfish were obtained from the Aquaculture Research Station at Louisiana State 
University, and were used as blank crawfish to validate a method to test for chloramphenicol, 
florfenicol, enrofloxacin, ciprofloxacin, and sarafloxacin using liquid chromatography—mass 
spectrometry. In short, the tissue was extracted with dilute acetic acid and acetonitrile with added 
sodium chloride. After centrifugation, the extract was evaporated to dryness with nitrogen and 
reconstituted in mobile phase. The extract was passed through a syringe and 0.2µm PVDF 
membrane filter into an auto-sampler vial. A Waters Acquity TQD LC/MS/MS operated in the 
positive and negative ion mode; ciprofloxacin, enrofloxacin, and sarafloxacin in positive ion 
mode, and florfenicol and chloramphenicol in negative ion mode.  Results indicated acceptable 
method performance characteristics for selectivity, linearity, accuracy (recovery), precision 
   
 
viii 
(RSD), and MDL and LOQ. Though ciprofloxacin did show some of the lowest recoveries, and 
chloramphenicol did have quite high RSD values. Retail samples tested negative for most of the 
veterinary drug residues with the exception of chloramphenicol in one Louisiana brand at an 
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 CHAPTER ONE: INTRODUCTION 1
Annual global aquaculture production has more than tripled within the past 15 years1, 
similarly, farm-raised crawfish production and value has increased—with a 25 percent increase 
in 20142. In the United States, Louisiana accounts for the majority of U.S crawfish sales and 
consumption, with demand being met from imported crawfish primarily from China. As demand 
for aquaculture products rises, cultivation methods will intensify leading to non-hygienic and 
stressful conditions that will rely on heavy amounts of antibiotics administered in fish feed in 
order to combat disease1. Many times farmers turn to unapproved drugs, especially since 
relatively few new veterinary drugs are approved for aquaculture. Furthermore, countries that 
export crawfish to the U.S., specifically developing countries, are subject to fewer regulations 
and lower production standards. 
In the United States there are no approved antibiotic drugs for the production of crawfish 
or shrimp3, yet in the past chloramphenicol has been detected in crawfish imported from China, 
and other veterinary drug residues, such as the fluoroquinolones, have been detected in other 
seafood aquaculture products. The USFDA has identified a number of aquaculture drugs that are 
of high enforcement priority and not approved for use in the U.S.; these drugs include 
chloramphenicol, nitrofurans, fluoroquinolones and quinolones, malachite green, and steroid 
hormones4. Florfenicol is one of the few antibiotics approved for use in aquaculture in the U.S., 
though only for salmon and catfish.   
Aquaculture is expected to increase to 40% of total global seafood production5, and with 
this potential increase it is imperative that there is a method to monitor antibiotic residues in 
order to ensure the safety of the food supply and protect public health. Chloramphenicol can 
cause adverse side effects such as irreversible aplastic anemia, and the widespread use of these 
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antibiotics can trigger antibiotic resistant pathogens that can be transmitted to humans and hinder 
the use of important antibiotics used to treat human infections. In order to lessen these adverse 
effects, aquaculture products need to be tested to ensure they are following USFDA guidelines 
and do not contain detectable antibiotic residues.  
Therefore, it is essential to have a rugged method that is efficient of both time and 
materials to analyze crawfish for a variety of antibiotics. Currently the FDA has only published a 
method for chloramphenicol in crawfish, and lacks a method that looks at multiple antibiotic 
residues. Consequently, the purpose of this investigation was to develop a single liquid 
chromatography-mass spectrometry method for chloramphenicol, florfenicol, enrofloxacin, 










   
 
3 
 CHAPTER TWO: LITERATURE REVIEW 2
2.1 Crawfish 
2.1.1 Production and Consumption 
In Louisiana scientists have scientifically described specimens of what appear to be 39 
distinctive species of crawfish6. The Louisiana crawfish harvests however are only composed of 
two species—the red swamp crawfish Procambarus clarkii and to a lesser extent the white river 
crawfish Procambarus zonangulus7.  The red swamp crawfish is the most desired species in the 
marketplace; they live two years or less, have high juvenile survival, and are capable of 
spawning year-round in the southern United States with some reproducing more than once per 
year7.  Most crawfish in Louisiana is farm raised in shallow earthen ponds8, and is the state’s 
most valuable aquacultural commodity2.  Wild crawfish make up about 12 percent of the harvest9 
and are mostly caught in the Atchafalaya Basin2.  
Crawfish production differs from most other aquacultural enterprises in three main ways. 
First, its primary feed is forage rather than formulated feeds; second, crawfish are often double-
cropped or rotated with other field crops; and third, because production is highly seasonal the 
fresh product cannot be marketed year-round9. Another difference is that crawfish ponds are not 
stocked with hatchery-reared young7. Instead, farmers rely on reproduction by unharvested 
crawfish from the previous year, or on mature crawfish (from natural habitats or culture ponds) 
that are stocked to produce young naturally7-8. This stocking is usually only needed in new ponds 
or when a pond has been idle for a year or more8.  
The primary forage crop for crawfish aquaculture is rice, though sorghum-sudangass or 
other natural vegetation also serves as a food source7. Supplemental feeding has not yet been 
shown to predictably increase yields or size of crawfish at harvest7. Over 50 percent of 
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Louisiana’s crawfish aquaculture is practiced in conjunction with rice production7, but other 
strategies of growing crawfish also exist such as monocropping. In monocropping systems 
crawfish is the sole crop harvested and production typically occurs in the same physical location 
for several production cycles or longer8. For aquaculture done in conjunction with rice, the 
production strategy is a crop rotation system. Two basic crop rotation systems exist: rice-
crawfish-rice and rice-crawfish-fallow (or rice-crawfish-soybean)8. Crawfish can either be 
produced in permanent rotation with a rice crop year after year in the same location, or in a field 
rotation with rice, with restocking of crawfish each rotational cycle7. Crawfish production 
follows the rice harvest, and the forage crop used for growing crawfish is the crop residue and re-
growth of the rice stubble after grain harvesting8.  
Crawfish aquaculture works well with rice production partly because the economics of 
rice production have weakened and many producers turned to crawfish as an accessory crop7. In 
addition, crawfish aquaculture fits well into existing rice farm operations through the use of 
marginal agricultural lands, crop rotations, and permanent farm labor and equipment during off-
peak farming periods7. Rice is also semi-aquatic and tends to survive well in flooded crawfish 
ponds, while also delivering plant fragments to the detrital pool7. Rice is typically grown and 
harvested during the summer, and crawfish are reared during autumn, winter, and early spring8. 
Current farming practices flood and drain ponds to mimic the natural flooding and drying 
cycle in the Atchafalaya River basin7. This control allows farmers to positively influence water 
quality, food resources, and other factors within their ponds7. Crawfish survive the dry intervals 
by digging or retreating to burrows where they can avoid predators, acquire the moisture 
necessary for survival, and reproduce in safety8. The pond flooding, as well as rainfall, allows 
the emergence of crawfish that have been living inside the burrows8.  
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 Harvesting crawfish relies upon the passive technique of baited traps8. Harvesting occurs 
generally from March through June, when densities of marketable crawfish are highest and 
crawfish are most active7. Since marketable crawfish are continual over much of the season, 
regular and frequent harvests are necessary, the duration of which is influenced by cost of 
harvesting, marketing price, and catch8. Harvesting frequently is also necessary due to the 
aggressive and territorial nature of crawfish; harvesting removes the larger individuals from the 
population, reducing aggression and leaving space and food resources for undersized crawfish to 
thrive7. 
2.1.2 Market and Trade 
The first record of a commercial crawfish harvest in the United States was in 1880 where 
23,400 pounds were harvested with a value of $2,1407. In 2014 there was a 25 percent increase 
in farm-raised crawfish production and value, with a production of 127 million pounds of 
crawfish valued at $172 million2. According to the 2005 U.S. Census of Aquaculture, Louisiana 
accounted for 96.4 percent of U.S. crawfish sales9 with small harvests of farmed crawfish 
occurring in other states, such as Texas, Arkansas, Mississippi, Alabama, and the Carolinas7.  
The U.S International Trade Commission found that U.S. consumption of crawfish tail meat 
fluctuated between 1997 and 2002, but was 178.7 percent higher in 2002 than in 199710. Most of 
the U.S. consumption occurs in Louisiana; in 2002 per capita consumption was 10.4 pounds, 
whereas the rest of the United States was only at 0.25 pounds11.  
Louisiana is the largest producer of crawfish in part because the red swamp crawfish 
lifecycle is well-suited to the annual sequence of spring flooding and summer dry period 
common to large river systems and floodplains in the southern U.S.8. Additionally, regional 
demand is high and fuels the growth of the aquaculture industry.  Global expansion of the red 
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swamp crawfish in pond culture is unlikely however, due to concerns associated with non-native 
introduction and this species ability to wreak havoc in ecological sensitive habitats8. The red 
swamp crawfish is quite hardy and adaptive, which allows it to out-compete some aquatic 
species and cause devastation to key plants8. Moreover, it is a suspected vector of the crayfish 
plague fungus, which was notorious for eliminating many populations of native European 
crayfish8.   
Most crawfish is sold live as whole crawfish or fresh tail meat, with some being sold as 
frozen tail meat11. Live crawfish are sold primarily for crawfish boils in the spring, and peeled 
tail meat is used in various Cajun dishes that are consumed year-round11. When crawfish are 
abundant or when live markets become saturated, a portion of the annual crop is processed and 
sold as fresh or frozen abdominal or “tail” meat7. The smaller crawfish are usually processed for 
the tail meat market, leaving the larger ones for the more profitable live market7. Most fresh 
crawfish tail meat is sold during the season in which domestic crawfish are harvested, as well as 
to the region in and around Louisiana due to its short shelf life10. It is for these reasons that about 
70 percent of Louisiana’s production of crawfish is consumed in Louisiana and neighboring 
states11. Most frozen crawfish tail meat is sold during the off-season, and has the ability to be 
sold outside of the Louisiana region10.  
In order to balance the U.S. demand for crawfish tail meat, frozen meat is imported, 
primarily from China, but also from Spain and Trinidad and Tobago10. Domestic crawfish tail 
meat and imports are direct competitors in the U.S. market; market participants note that quality 
and consistency is the most important factor in their purchasing decision, followed by pricing 
differences10. Subject import volume increased 279.3 percent between 1997 and 2002, well in 
excess of the 178.7 percent increase in U.S. consumption over that period10. Increases in subject 
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import volume and market share coincided with suppressed domestic prices and declines in 
domestic production, sales volumes, capacity utilization, employment, and financial 
performance12. Another result of the imports from China is that now less than ten percent of the 
annual domestic crop is processed for tail meat7. Prior to Chinese imports there were over 100 
licensed crawfish processors in Louisiana, but as of recently that number was in the low 30’s7. 
This has lead to a dramatic reduction in processing (peeling) capacity in Louisiana, and as a 
result each year thousands of tons of smaller crawfish are not harvested7.  
2.2 Aquaculture 
2.2.1 Veterinary Drug Use in Aquaculture 
Aquaculture is the farming of aquatic organisms, including finfish and shellfish, by 
individuals, groups, or corporations using interventions such as feed, medications, controlled 
breeding, or containment that act to enhance production1. Evidence shows aquaculture existed in 
Egypt and China as early as 2500 B.C. and 1100 B.C, respectively1. Currently annual global 
aquaculture production has more than tripled within the past 15 years, and by 2015 was predicted 
to account for 39% of total global seafood production by weight1. The primary production 
facilities are located in a few Asian countries, and China alone accounts for about 71 percent of 
total global aquaculture production1.  
Global aquaculture will only continue to grow as the world fisheries become overfished 
and demand for seafood continues to increase. As demand for aquaculture products rises, 
cultivation methods will intensify to include high stock density and volume, and heavy use of 
formulated feeds containing antibiotics, antifungals, and other pharmaceuticals1. As a result of 
the non-hygienic and stressful conditions present in aquaculture facilities, the risk for bacterial 
infection is high1. In order to combat disease, heavy amounts of antibiotics are administered in 
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fish feed prophylactically at sub-therapeutic concentrations (disease prevention) and 
therapeutically (disease treatment), which can then lead to residual concentrations left in 
seafood1. Antibiotics are typically applied in three ways at sub-therapeutic concentrations: a 
single antibiotic for an extended period; a rotating class of multiple antibiotics; and a gradient 
regimen where antibiotic concentrations are gradually increased13.  
There are no uniform global standards for aquaculture and antibiotic use, and in the case 
of developing countries there are limited or no regulations in place. When regulations do exist, 
there is little enforcement by local authorities. New animals drugs in the United States that are 
added to aquaculture feed are subject to FDA approval, but the same cannot be said for other 
countries—particularly the developing countries where most aquaculture takes place13.  
Furthermore, relatively few new animal drugs have been approved for aquaculture in the US, and 
as a result many aquaculture growers may use unapproved new animal drugs or general-purpose 
chemicals not permitted for drug use14.  
2.2.2  Environmental Impacts  
The main environmental impacts of marine aquaculture include biological pollution, 
organic pollution and eutrophication, habitat modification, and chemical pollution15. In terms of 
biological pollution, aquaculture facilities can unintentionally release farmed fish and their 
parasites and pathogens into the environment15. Escapes of these organisms could impact the 
wild aquatic species in the area by out-competing native species, and through the introduction 
and spread of disease. Aquaculture operations can negatively impact water quality by 
contributing to nutrient loading and eutrophication through wastes entering the aquatic 
environment15. These factors can damage natural ecosystems and the species living in them, as 
well as facilities obstructing wild animals’ use of their natural surroundings15. Lastly, 
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aquaculture results in chemical pollution through the use of antibiotics, parasiticides, pesticides, 
hormones, pigments, minerals, and vitamins15. Research indicates that 70-80% of the drug used 
in aquaculture ends up in the environment16 with the potential to spread into and persist in the 
environment. One study found the 90% dissipation time (DT90) for enrofloxacin and florfenicol 
to be greater than 150 days in terrestrial soil and marine sediments17. These environmental 
residues can then promote the development of multiple antimicrobial-resistant bacteria16-17.  
2.2.3 Human Health Impacts  
The aquaculture process and use of antibiotics can contribute to adverse human health 
impacts through the accumulation of residual antibiotic in edible tissue, and the development of 
antibiotic resistant bacteria.  Between the 1990’s and today, the number of publications linking 
bacterial resistance to seafood has increased by 800%5. Bacterial antibiotic resistance arises 
through mutations in bacterial DNA or through horizontal gene transfer mechanisms1. The 
resistance genes in fish pathogens are often the same as those found in human pathogens, and 
most of these genes are transferable16. Additionally, some antibiotics used in aquaculture are also 
used in human medicine; therefore, if antibiotic resistant bacteria occur in aquaculture this could 
impede the use of some important antibiotics used to treat human infections15.  
The use of unapproved drugs or misuse of approved drugs in aquacultured products poses 
a potential human health hazard4. When a veterinary drug does not have or exceeds the 
maximum residue limit (MRL) or has not been approved for use in aquaculture, the risk to the 
public health is not known and at certain concentrations may represent a hazard to consumers16. 
Generally, low level exposures to antibiotic residues are not likely to cause immediate toxic 
effects among the general public; however, the chronic effects are largely unknown1. The 
potential immediate and long range human health consequences may include hypersensitivity 
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reactions, toxicity-related reactions, potential carcinogenic and mutagenic effects, and increasing 
prevalence of antibiotic-resistant microorganisms14.   
 The greatest risk to public health is assumed to be the development of a reservoir of 
transferable resistance genes in bacteria in aquatic environments, which can further disseminate 
and eventually become antibiotic resistant human pathogens16.  Even low-level exposures well 
below regulatory limits can still promote the emergence of multi-drug resistant microorganisms5. 
Antimicrobial resistant bacteria may have a range of adverse effects on human health including 
increased frequency and duration of illness, treatment failure, and loss of therapeutic options14.   
Direct spread of resistance from aquatic environments to humans may occur from consumption 
of aquaculture food products or through drinking water, and direct contact with water or 
aquaculture food products16. Specific populations at risk include individuals working in 
aquaculture, populations living around these facilities, and consumers who regularly prepare and 
eat aquacultured products1.  
2.3 Antibiotic Residues Impacting Food Safety   
In the United States, the FDA’s Center for Veterinary Medicine (CVM) has identified 
high enforcement priority aquaculture drugs that historically have been used without FDA 
approval4. High priority drugs are known or suspected carcinogens; known serious toxicological 
hazards; suspected serious toxicological hazards believed to have substantial use in aquaculture; 
and antimicrobials likely to confer bacterial resistance to drugs used in human medicine18. These 
drugs should not be used in fish that is to be consumed and include chloramphenicol; nitrofurans; 
fluoroquinolones and quinolones; malachite green; and steroid hormones4. No aquacultured 
species may contain a residue of an unapproved drug, and may not contain a residue level of an 
approved drug that is above FDA tolerance limits4. Based on which drugs are often used in 
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aquaculture, the compounds chosen as target analytes were chloramphenicol, florfenicol, 
enrofloxacin, ciprofloxacin, and sarafloxacin.  
2.3.1 Chloramphenicol  
Chloramphenicol (CAP) (Figure 2.1) is produced for commercial use by chemical 
synthesis, and is biosynthesized by the soil organism Streptomyces venezuelae and several other 
Actinomycetes19. It was the first mass produced antibiotic and was widely used globally as a 
human antibiotic due to its effectiveness against typhoid20. Chloramphenicol is a broad-spectrum 
antibiotic that is highly potent and active against gram-positive and gram-negative bacteria21. It 
is not adsorbed to clay or soil and is thus highly mobile; the half life in soil at 25°C is 4.5 days, 
in pond water at 25°C and pH 8 the half life is 10.3 days, and the half life at 37°C and pH 6 is 
20.8 days22. Bioconcentration in aquatic organisms is not likely as the log Kow is 1.1422. 
 
Figure 2.1. Chemical structure of chloramphenicol. 
Presently it is scarcely used in human medication20, and is not approved for use in food-
producing animals14. The restrictions are due to its risk of severe human disease, particularly an 
idiosyncratic dose-independent aplastic anemia in humans, as well as other concerns about the 
genotoxicity of the drug and its metabolites, and its embryo and fetotoxicity16. In addition, it is a 
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suspected carcinogen and may affect the reproductive system in humans14. Even low 
concentrations of chloramphenicol can cause aplastic anemia, a form of anemia when the bone 
marrow ceases to produce sufficient red and white blood cells20. It is an irreversible condition 
with a 70% case fatality rate; those that do recover experience a high incidence of acute 
leukemia16. A syndrome of cyanosis and cardiovascular collapse known as Grey syndrome may 
also occur, especially in newborn babies21. Due to these risks, a safe level of exposure has not 
been determined and as such no ADI (acceptable daily intake) or MRLs (maximum residue 
levels) are established14, 16. However, there are no reported cases of aplastic anemia due to 
consumption of chloramphenicol residues in foods16.  
Chloramphenicol is banned in food-producing animals in the United States, the European 
Union, Canada, Australia, Japan, and China20. However despite these restrictions, it is one of the 
most commonly used antibiotics by aquaculture producers, and has been detected in national 
monitoring programs in products such as shrimp and crawfish5, 16. In 2001 shrimp imported into 
Europe from Asian countries were found to have between 1 and 10 ppb of chloramphenicol20. In 
2003 the European Union banned the import of shrimp and crawfish from China because 
chloramphenicol had been found23. Additionally, as recently as 2014 Denmark had detected 
chloramphenicol in frozen red swamp crawfish from China at 1.2, 1.95, and 2.49 ppb24. 
Furthermore, since chloramphenicol has a zero-tolerance limit, it is important that these 
monitoring programs are able to detect it at low levels in biological samples. Therefore, a 
minimum required performance limit (MRPL) for chloramphenicol was set at 0.3 µg/kg (ppb) in 
food of animal origin in the EU, United States, and China25.  
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2.3.2 Florfenicol  
Florfenicol (FF) (Figure 2.2) is a synthetically produced broad-spectrum antibacterial 
agent specifically developed for veterinary use17. Florfenicol was first evaluated as a therapeutic 
agent in fish in the early 1980s and is still used today16. It has a wide range of activity similar to 
that of chloramphenicol, though it does not carry the risk of inducing human aplastic anemia26. 
Florfenicol lacks the nitro group located on the chloramphenicol aromatic ring that has been 
associated with the chloramphenicol induced non-dose related irreversible aplastic anemia in 
humans26. However, it is theoretically possible that florfenicol could cause some dose-dependent 
reversible bone marrow suppression, as chloramphenicol and thiamphenicol are known to do26.  
Florfenicol also has similar characteristics to that of chloramphenicol, it is highly mobile in soil 
with half lives in three sediment-water systems ranging from 8 to 19 days, and is not likely to 
bioaccumulate (log Kow of 0.37)27.  
 
Figure 2.2. Chemical structure of florfenicol. 
Similar to chloramphenicol, florfenicol is also one of the top antibiotics used by heavy 
aquaculture producers5. Due to the ban of chloramphenicol in food-producing animals, 
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florfenicol has been widely used in veterinary medicine to prevent and treat infection with 
sensitive bacteria17. In a survey in China looking at shrimp and carp aquaculture, florfenicol was 
found to be the second most widely used antibiotic28. Today it is approved for use in the US for 
medicated feed to control mortality in catfish and salmonids4.  
2.3.3 Fluoroquinolones: Enrofloxacin, Ciprofloxacin, and Sarafloxacin  
Enrofloxacin (ENR), ciprofloxacin (CIP), and sarafloxacin (SARA) (Figure 2.3) are later-
generation fluoroquinolones (FQs)29, a class of broad-spectrum synthetic bacterial medicines 
effective against gram-negative bacteria17. They are effective against these bacteria through the 
inhibition of bacterial DNA gyrase, thus preventing DNA synthesis30. Unlike CAP and FF, 
fluoroquinolones bind tightly to soil and are immobile, though similarly they have little chance 
to bioaccumulate. Fluoroquinolones are a critically important class of synthetic antibiotics as 
they are used to treat serious infections in humans14. Both the FDA and WHO ranked them as 
essential antimicrobial agents for human health and animal health and welfare14. Enrofloxacin is 
used for non-food producing animals, ciprofloxacin is approved to treat human diseases and is 
not used in veterinary applications, and sarafloxacin was developed only for use in animals31. In 
mammalian and nonmammalian species, enrofloxacin is N-dealkylated to its metabolite 
ciprofloxacin, which contributes to enrofloxacin’s activity and is itself a potent antimicrobial32.  
The most commonly used fluoroquinolones are enrofloxacin and ciprofloxacin in human 
medicine and animal husbandry17. Sarafloxacin was the first fluoroquinolone approved in the 
United States for use in food-producing animals, but has been withdrawn from the market owing 
to concerns about microbial resistance33. In China, sarafloxacin is licensed for use in aquaculture 
as it has been shown to effectively control common bacterial infections of cultured fishes31. 
Enrofloxacin is also licensed for use in aquaculture in China32, and is commonly administered as 
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in-feed antibacterials17. In the survey in China looking at shrimp and carp aquaculture, 
enrofloxacin was the fourth most widely used antibiotic28. Ciprofloxacin on the other hand is 
banned for use in aquaculture in China28.  
 
Figure 2.3. Chemical structure of the fluoroquinolones: enrofloxacin, ciprofloxacin, and 
sarafloxacin. 
 
In the US, the FDA prohibited the extra-label use of fluoroquinolones in food producing 
animals in 1997 based on evidence that widespread use in food animals would promote the 
evolution of drug-resistant pathogens that could be transmitted to humans through the food 
chain14. As a result, the ability to treat human diseases with these antimicrobial drugs may have 
been compromised14. Furthermore, none of the fluoroquinolones are approved in the United State 
for use as aquaculture therapeutic agents, and such use is considered to be unsafe14, 30.  
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2.4 Regulations for Antibiotic Use in Aquaculture  
2.4.1 International Regulations  
The World Trade Organization’s Sanitary and Phytosanitary Agreement (SPS agreement) 
states that countries have the right to establish measures and the appropriate level of protection to 
safeguard the life and health of their population. Scientific evidence should be used to establish 
these control measures, and these measures should not be taken to only favor the domestic 
industry34. Many countries work together to establish measures of protection; for example, the 
U.S. and Canada, under the United States and Canada Free Trade Agreement, have harmonized 
human food safety requirements for approval of drugs used in food animals, and have agreed on 
identical tolerances for 37 animal drugs13. The U.S., the European Economic Community (EEC), 
and Japan are involved in a trilateral program, the International Cooperation on Harmonisation of 
Technical Requirements for Registration of Veterinary Medicinal Products (VICH)35, and as a 
result also have similar requirements for animal drug approval and tolerance levels13.  
An international effort for risk assessment is with the World Health Organization (WHO) 
and Food and Agriculture Organization (FAO) Joint Expert Committee on Food Additives 
(JECFA), which evaluates human food safety data on selected animal drugs for the Codex 
Committee on Residues of Veterinary Drugs in Foods13. JECFA is a committee of animal drug 
experts from the codex committee countries, and works to evaluate toxicological and residue 
data on priority animal drugs, as well as establishing tolerance levels13. Priority animal drugs are 
established by the Codex Committee on Residues of Veterinary Drugs in Foods based on 
veterinary drugs that may pose a consumer safety problem and/or that may have potential 
adverse impacts on international trade34.  
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In China, there are several laws and regulations that manage the aquaculture industry, 
these include the Fisheries Law of the People’s Republic of China, the Marine Environment 
Protection Law of the People’s Republic of China, the Law of the People’s Republic of China on 
Agricultural Product Quality Safety, and the Food Safety Law of the People’s Republic of 
China36. The Fisheries Law states that the use of antimicrobials in Chinese aquaculture should be 
appropriate and that the wastewater effluent discharges should not pollute the surrounding 
aquatic area, but lacks a clear statement on how this can be evaluated and avoided37. In terms of 
surveillance of veterinary medicine use in Chinese aquaculture, the Fish Drug Surveillance 
Department was established in 2005, and the Ministry of Agriculture has organized a national 
inspection team to conduct inspections in major aquaculture producing areas28. However, despite 
the appearance of regulation by multiple government departments, aquaculture facilities in China 
operate largely without permits36.   
2.4.2 U.S. Regulations  
The Federal Food, Drug and Cosmetic Act (FFDCA) and its amendments determine the 
legal marketing and use of veterinary drugs in the U.S.35. The USFDA’s Center for Veterinary 
Medicine (CVM) has responsibility for approval and monitoring activities that govern animal 
drug use in the U.S. They work to ensure that new drugs pass a rigorous approval process, and 
regulate the manufacture and distribution of drugs intended for food and companion animals13. 
Drugs are approved by the FDA for specific species, dose, route of administration, frequency of 
administration and conditions of use35. Labeled withdrawal times must be followed to ensure that 
no harmful drug residues are present in the edible tissue of the animal when it is harvested for 
human consumption14. If there is no tolerance established, any amount of drug residue found is 
considered a violation and renders the product adulterated14. The FDA may also prohibit extra-
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label use of certain drugs that pose a public health concern, which includes chloramphenicol and 
fluoroquinolones35.  
 The Seafood Hazard Analysis and Critical Control Point (HACCP) Regulation was 
promulgated under the FFDCA, and requires both domestic and foreign processors to prevent the 
introduction of contaminants into the seafood they process or that they transport through 
commerce14. FDA-CVM cooperates with USDA’s Food Safety Inspection Service and FDA’s 
Center for Food Safety and Applied Nutrition to monitor for unsafe residues in food and to take 
enforcement action when there are violations35. The regulatory sanctions that FDA has available 
to apply to domestic processors that are non-compliant are warnings letters, seizure of products, 
injunction against further non-compliant practices, or prosecution.  The options available with 
respect to foreign processors that are non-compliant include placing the affected products on 
import alert for detention without physical examination14.  
Routine testing of aquaculture drug residues was initiated in 2002, under the 
Chemotherapeutics in Seafood Compliance Program, to collect and test samples of selected 
imported and domestic aquacultured seafood products for the presence of unapproved chemical 
compounds14. Any seafood products containing unapproved animal drug residues are considered 
to be adulterated under the FFDCA and are not permitted to be sold in, or imported into the 
U.S.14. However, testing on imported aquaculture products is limited to a few chemicals and the 
frequency of testing is rather low compared to the amount of imported aquacultured products that 
are potentially contaminated1. For example, in 2007 approximately 868,000 fish and fishery 
products were imported into the U.S., and FDA examined or obtained samples from only 
approximately 1.2 percent of those14.  
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2.5 Method Validation  
In order to develop a method that can be used by other agencies to identify animal drug 
residues, it is important that it follow the proper validation protocol. Some general guidelines to 
assess method performance are to prepare and analyze method blanks, matrix blanks, and matrix 
spikes of known concentration38.  Use of various types of blanks allows the analyst to insure 
measured concentrations are not influenced by background contamination or matrix interference. 
Matrix blanks are used to establish background level (presence or absence) of analytes and to 
verify that sample matrix and equipment used does not interfere with or affect the analytical 
signal38. Matrix spikes, or laboratory-fortified matrix, includes fortifying blank matrix with a 
known concentration of analyte, and can be used to calculate spike recoveries, accuracy, and 
precision38. The laboratory-fortified matrix should be made up of known concentration of at least 
three different concentration levels: low, middle, and high, and carried through the complete 
sample preparation procedure39.   
Performance characteristics that should be evaluated in order to validate a new 
quantitative method should include selectivity, linearity, accuracy (recovery), precision 
(repeatability), limit of detection, and limit of quantitation38. It is understood that with a large 
multi-residue method not all analytes will meet recommended acceptability ranges, but the 
performance for each compound should be tested and reported so that the accuracy and precision 
are known and are sufficient for the intended purpose of the method38.   
Selectivity is the ability of an analytical method to differentiate and quantify the analyte 
in the presence of other components in the sample40. For negative control samples, there should 
be no interference peaks near the retention times for all analytes. Linearity is shown with a 
calibration curve displaying the relationship between instrument response and known 
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concentrations of the analyte, and is generated for each analyte by spiking the matrix with the 
analyte at known concentrations40. It should consist of five to eight concentrations prepared from 
a common stock and performed in duplicate41. The standard curve linear regression coefficient of 
determination, R2, should be greater than or equal to 0.99539.  
Accuracy describes the closeness of mean test results obtained by the method to the true 
value of the analyte, and is determined by replicate analysis of samples containing known 
concentrations of the analyte40. Accuracy should be measured as recovery for a minimum of 
three replicates at each of three concentrations in the range of expected concentrations39. 
Recovery values should range from 40%-120% for method levels of 1 ppb, and 60-115% for 
method levels of 10 ppb38. The precision of an analytical method is the agreement between a set 
of replicate measurements without assumption of knowledge of the true value39. Precision can be 
further classified as repeatability and intermediate precision. Repeatability is the precision 
obtained under conditions where independent test results are obtained with the same method on 
identical test items in the same test facility by the same operator using the same equipment 
within short intervals of time, and intermediate precision is within-laboratory precision obtained 
under variable conditions such as different days38. Repeatability precision for method levels of 1 
and 10 ppb should be between 11-44% (acceptable values of RSDr are between ½ and 2 times 
the RSD of 22%)38.  
The limit of detection (LOD) is the lowest concentration of analyte in a sample that can 
be determined to be statistically different from a blank39, and is often referred to as the method 
detection limit (MDL)38. MDL is the minimum concentration of a substance than can be 
measured and reported with 99% confidence that the analyte concentration is greater than zero, 
and is determined from analysis of a sample in a given matrix containing the analyte39. The limit 
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of quantitation (LOQ) is the level above which quantitative results may be determined with 
acceptable accuracy and precision39. It is defined as equal to 10 times the standard deviation of 
















   
 
22 
 CHAPTER THREE: MATERIALS AND METHODS 3
 
3.1 Chemical Reagents and Materials  
LC-MS grade acetonitrile from EMD Millipore Corp (Billerica, MA), reagent grade 
glacial acetic acid from Ricca Chemical Company (Arlington, TX), and sodium chloride from 
Fisher Scientific (Fair Lawn, NJ) were used for sample preparation. LC-MS grade acetonitrile 
(Fisher Chemical, Fair Lawn, NJ), Milli-Q purified water, and formic acid (Acros, New Jersey) 
were used for the mobile phase. Acetic acid solution (1% v/v) was prepared with water purified 
to 18.2 megaohms by a Millipore Sigma (Billerica, MA) filtration system. Ceramic homogenizer 
pellets were obtained from Agilent Technologies (Santa Clara, CA). Polypropylene syringes and 
17 mm PVDF 0.2 µm syringe filters were purchased from Thermo Scientific (Waltham, MA). 
The LC column used was an Acquity UPLC BEH C18, 1.7 x 50 µm purchased from Waters 
(Milford, MA).  
3.2 Standard Solutions 
Neat standards of enrofloxacin (ENR) (≥98.0%), ciprofloxacin (CIP) (≥98.0%), 
sarafloxacin (SARA) (≥97.2%), florfenicol (FF) (analytical standard, for drug analysis), and 
chloramphenicol (CAP) (≥98.0%) were purchased from Sigma Aldrich (St. Louis, MO).  
Selected standard solution concentrations were made based on a method developed for the 
analysis of veterinary drug residues in frog legs and other aquacultured species43. Separate stock 
solutions for each analyte were prepared in acetonitrile at concentrations of 500 µg/mL (ppm) for 
ENR, CIP, SARA, and FF, and 200 µg/mL (ppm) for CAP, and were reported to be stable for 
one year43. An intermediate mixed standard solution was prepared in acetonitrile at 
concentrations of 500 ng/mL (ppb) for ENR, CIP, SARA, and FF, and 100 ng/mL for CAP, and 
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was reported to be stable for one month43. Additional details of daily standards prepared in blank 
matrix (containing ≥ 95% matrix), as well as fortified standards in tissue are given in Table 3.1.  
Table 3.1. Nominal standard solution concentrations. 
  
Approx concn of stds (ng/mL) in matrix 
(fortified stds (ng/g) in tissue) 
Level  ENR, CIP, SARA, FF CAP 
2x 25 (10) 5 (2) 
1x 12.5 (5) 2.5 (1) 
0.5x 6.25 (2.5) 1.25 (0.5) 
aThe extraction procedure concentrates samples by a factor of 2.5. 
3.3 Sample Procurement   
Domestic and imported frozen retail crawfish were obtained from local grocery stores, 
and transported to the Department of Environmental Science at Louisiana State University 
Agricultural and Mechanical College in Baton Rouge, LA. The samples were stored at -80°C 
until further processing.  For method validation, about 1-2 pounds of live crawfish were obtained 
from Dr. C. Greg Lutz at the Aquaculture Research Station at Louisiana State University in 
Baton Rouge, LA. These crawfish were put into the -80°C freezer overnight, thawed and peeled 
the next day, and put into the freezer until further processing.   
3.4 Extraction Procedure  
Crawfish were extracted based on a method developed for the analysis of veterinary drug 
residues in frog legs and other aquacultured species43. A portion of the frozen crawfish tails (2.5 
± 0.03 g) was weighed into a 50 mL polypropylene centrifuge tube. Validation samples were 
fortified by adding an appropriate amount of the intermediate mixed standard to the semi-frozen 
tissue. After sitting for approximately 15 minutes, 2.0 g of sodium chloride, 10.0 mL of 
acetonitrile, and 5.0 mL of 1% acetic acid in water were added to each tube. The samples were 
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homogenized using a Waverly H100 handheld homogenizer (Waverly, IA) for less than a 
minute. A ceramic homogenizer pellet was then added to each tube and placed on a vortex genie 
2 (Scientific Industries, Bohemia, NY) at maximum speed (1700-2300 rpm) for 8 minutes. Later 
on in method development a Robot Coupe Blixer 2 food processor (Ridgeland, MS) became 
available, and was used to grind the crawfish tails prior to extraction. The Robot Coupe 
extraction method was used for analysis of the seven fortified blanks used to calculate MDL and 
LOQ, and for retail sample analysis. Validation samples were fortified by adding an appropriate 
amount of the intermediate mixed matrix to the already ground tissue, and allowed to sit for 15 
minutes. Next 2.0 g of sodium chloride, 10.0 mL of acetonitrile, 5.0 mL of 1% acetic acid in 
water, and a ceramic homogenizer was added to each tube. Since the tissue was already ground, 
the sample was mixed using the vortex genie 2 and the ceramic homogenizer pellet, and did not 
need to be homogenized by hand. From this point everything was treated similarly. 
 After the tubes were vortexed, they were placed in a centrifuge at 10°C for 
approximately 8 minutes at about 3500 rpm. The top organic layer was removed with a Pasteur 
pipet and placed into another clean 50 mL centrifuge tube. An additional 10 mL of acetonitrile 
was added to the original tissue mix, and put back on the vortex genie at maximum speed and 
into the centrifuge at 3500 rpm for 8 minutes each. The top organic layer was again removed and 
combined with the other acetonitrile layer, and then evaporated on an N-EVAP from 
Organomation Associates, Inc. (Berlin, MA) heated to 55°C for approximately 60 minutes. The 
residue was reconstituted in 1.0 mL of 10% acetonitrile and 0.1% formic acid (overall) in water, 
and then sonicated for about 5 minutes. After sonication the samples were centrifuged at 3500 
rpm for 8 minutes at ambient temperature. The extracts were each transferred to a 1 mL plastic 
syringe and passed through a 0.2 µm PVDF syringe filter into an LC vial for analysis.  
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3.5 Liquid Chromatography-Mass Spectrometry Instrumentation 
Compounds were separated by liquid chromatography and quantified using a triple quad mass 
spectrometer in multiple reaction monitoring (MRM) mode. MRM is a targeted mass 
spectrometry technique that allows the detection and quantification of specific molecules in 
complex mixtures44. Separate methods were used for positive and negative MS/MS analysis 
(Table 3.2). Samples were analyzed with a Waters Acquity TQD LC/MS/MS initially in either 
positive or negative ion mode and then re-injected for analysis using methods for the opposite 
polarity; CIP, ENR, and SARA were measured in positive ion mode, and FF and CAP in 
negative ion mode. All compounds were separated on an Acquity UPLC BEH C18, 1.7 x 50 µm 
column using a gradient mobile phase consisting of water with 0.1% formic acid (mobile phase 
A) and acetonitrile with 0.1% formic acid (mobile phase B) run in gradient mode (Table 3.2).  
3.6 Data Analysis  
For the estimation of accuracy (recovery) and precision, blank crawfish from the 
Aquaculture Research Center were fortified at three different concentration levels: 10.0, 5.0, and 
2.5 ng/g for ENR, CIP, SARA, and FF, and 2, 1, and 0.5 ng/g for CAP, corresponding to 0.5, 1, 
and 2 times the level of interest (Table 3.1). Concentrations of the analytes were interpolated 
from a one-point matrix matched standard. Accuracy was calculated from the spike recoveries, 
using Equation 141.  
Recovery %=(Cf – Cu) x 100 / Ca        (1) 
Where Cf  is the concentration of the fortified sample, Cu is the concentration of the unfortified or 
“blank” sample, and Ca is the calculated (not analyzed) concentration of analyte added to the test 
sample41.  
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Table 3.2. Instrumental Parameters of the Waters Acquity TQD LC/MS/MS. 
Mass Spectrometry ES Pos ES Neg 
Capillary (kV) 3.84 2.29 
Cone (V) 40 30 
Extractor (V) 3 2 
Source Temperature (°C) 120 110 
Desolvation Temperature (°C) 400 450 
Desolvation Gas Flow (L/Hr) 500 600 
Argon Collision Gas Flow (mL/min) 0.18 0.19 
LC     
Column Acquity UPLC BEH C18, 1.7 x 50 µm 
Mobile Phase A Water with 0.1% Formic Acid 
Mobile Phase B Acetonitrile with 0.1% Formic Acid 
Flow Rate 0.3 mL/min 
 Column Temperature (°C) 30°C 
 Injection Volume 15 µL  
LC Gradient A B 
Initial Time 95% 5.0% 
1 min 95% 5.0% 
3 min 40% 60% 
5 min 5.0% 95% 
7 min 5.0% 95% 
7.1 min 95% 5.0% 
10 min 95% 5.0% 
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Precision, RSD, was calculated from the three different days of recovery data using 
Equation 241. 
RSD %= sr x 100 / x̄          (2) 
Where sr is repeatability standard deviation, and x̄ is the average spike recovery for the three 
days.  
 MDL was calculated according to the U.S. Environmental Protection Agency’s MDL 
procedure published in 40 CFR (Code of Federal Regulations) Part 136, Appendix B, rev. 1.1145. 
A minimum of seven aliquots of the sample are to be used to calculate MDL45, so in order to 
calculate MDL, LOQ, and within day RSD, seven blanks were fortified at the 0.5x level. The 
MDL was calculated by multiplying the standard deviation of those values by the t test value at 
the 99% confidence interval (MDL=standard deviation x 3.143 for one-tailed Student’s t test, 
n=7) per the EPA method for determination of the MDL45. LOQ is mathematically defined as 10 
times the standard deviation of the results for a series of replicates used to determine a justifiable 
limit of detection42, and therefore was calculated by multiplying the standard deviation of the 
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 CHAPTER FOUR: RESULTS AND DISCUSSION 4
 
4.1 Tuning the LC/MS/MS Method 
Prior to analysis of the samples, the mass spectrometer was tuned to each particular 
analyte to maximize signal intensity and establish product (daughter) ions. Multiple reaction 
monitoring (MRM) utilizes the three quadrupoles to select for specified transitions from one or 
more precursor ions to multiple product ions44. The fragmentation of target compounds to form 
product ions has been reported in the literature; the m/z values and molecular formulas for the 
most important ions are shown in (Table 4.1). MRM-MS sensitivity is dependent upon proper 
tuning of instrument parameters such as cone voltage and collision energy in order to generate 
optimal fragmentation and maximal signal transmission of the product ions44. Two MRM 
transitions were monitored for each analyte; the ion that showed the most intensity was used as 
the quantifier ion and the ion with less intensity was used as the qualifier ion (Table 4.2). 







Formula Refs  
CIP 332.22 288.1 C16H19FN3O+  
43 
  
245.11 C14H14FN2O+  
 
     ENR 360.25 342.13 C19H21FN3O2+  
43 
  
316.17 C18H23FN3O+  
 








151.91 C7H6NO3−  
 
     FF 356.05 335.82 C12H12Cl2NO4S- 
47 
    184.91 C8H9O3S-   
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 Standards in mobile phase were injected at decreasing concentrations to establish if these 
drug residues could reliably be detected at the level of interest.  The levels of interest (1x levels) 
were set using current testing target levels, also considered regulatory action target levels; these 
values are supported by CVM as sufficient for detecting the presence of each residue48. Target 
levels for the fluoroquinolones are 5 ng/g48, which was also chosen as the level of interest for 
florfenicol (Table 4.2). For chloramphenicol, regulatory laboratories look at the maximum 
required performance limit (MRPL), which is no more and no less than the concentration level 
that laboratories in the European Community should at least be able to detect and confirm49.  
Chloramphenicol currently has a MRPL of 0.3 ng/g in food of animal origin25, rather than the 
previous level of 1 ng/g. However, in this investigation the signal intensity was not sufficient for 
low level standards so the level of interest was set to 1 ng/g, which is consistent with the study 
for frog legs this method is based off of (Table 4.2)43. Additionally, there was some background 
contamination of chloramphenicol in the blank samples used for validation, likely due to its 
natural occurrence, so it was not possible to get an accurate reading below the 0.5x level, even 
though the signal was high.  
4.2 Method Validation and Quantitation of Target Residues in Crawfish 
4.2.1 Selectivity  
No interference peaks were found near the retention times for the selected transitions for 
the five analytes under the chromatographic conditions used for the negative control samples of 
solvent blank and reagent blank, with the exception for enrofloxacin’s qualifier ion 
(360.25>342.13). For the matrix blank samples used for validation, chloramphenicol was 
detected at low levels in all samples tested, therefore the blank areas were subtracted from 
fortified sample areas when calculating recovery and detection and quantitation limits. 
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 Table 4.2. MRM transitions used for detection and quantitation. 










332.22>245.11 40 20 2.34 5 
Enrofloxacin Positive 
360.25>316.17c; 
360.25>342.13 40 20 2.41 5 
Sarafloxacin Positive 
386.28>299.07c; 
386.28>342.10 40 30; 20 2.51 5 
Florfenicol Negative 
356.05> 335.82c; 
356.05> 184.91 30 10; 20 2.79 5 
Chloramphenicol  Negative 
321.04>151.91c; 
321.04> 256.89 30 20; 10 2.88 1 
a CE=Collision energy 
b The level of interest corresponds to 1x level 
c Primary MRM for quantitation 
 
Others have also found chloramphenicol levels when there is no known use of the antibiotic 
being used. Products of animal origin originating from Asian countries entering the European 
market were found to be noncompliant (containing CAP) on a regular basis, even when there was 
no history of chloramphenicol use in those countries50. The background levels of 
chloramphenicol are potentially due to chloramphenicol occurring naturally in soil and crops, 
which can then be taken up by the animal resulting in residues in animal products not due to 
illegal use of the drug51. In 2010 the detection of CAP in different families of Mongolian plants 
as well as in soil was reported, suggesting that CAP is produced in the soil and the plants absorb 
CAP through their root systems50. More recent studies suggest that CAP can be naturally 
produced in sterile and natural soils by soil bacteria and transferred to crops19, and another study 
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found 35% of cereal straw samples from the Netherlands, France, UK, Germany, and Denmark 
to contain CAP—with the highest level at 6.3 µg/kg51. 
4.2.2 Linearity  
The working range of the method was determined by analyzing 5 different calibration 
standards.  For matrix-matched calibration standards, concentrations were 76.0, 50.0, 25.0, 12.5, 
and 6.25 ng/mL for the FQs and FF, and 15.2, 10.0, 5.0, 2.5, and 1.25 ng/mL for CAP.  Linear 
regression analysis was used to calculate the calibration curve, which was linear between the 
lowest and highest concentration, with correlation coefficients ≥ 0.972 (Appendix Figure 7.1). 
Solvent standard curves were also generated using concentrations of 50.0, 25.0, 12.5, and 6.25 
ng/mL for the FQs and FF, and 10.0, 5.0, 2.5, and 1.25 ng/mL for CAP. Linear regression curves 
were linear with correlation coefficients ≥0.963 (Appendix Figure 7.2).   
4.2.3 Accuracy and Precision  
To determine recoveries (measure of accuracy), blank samples were fortified with a 
mixed standard solution at three different levels of concentration on three different occasions 
(October 12, 2017; October 25, 2017; and November 1, 2017). After quantifying the fortified 
samples using a one-point matrix matched standard, recovery was calculated according to 
Equation 1, and results are given in Table 4.3. Overall, the mean recoveries ranged from 36.7 to 
97.6%, and generally fell within the acceptance criteria of 40-120% for method levels of 1 ppb, 
and 60-115% for method levels of 10 ppb38.  
Precision (RSD) for ciprofloxacin, enrofloxacin, sarafloxacin, and florfenicol was 
acceptable with values of 2.68-32.46% across the three days (Table 4.3). However, precision 
(RSD) for chloramphenicol was quite high across the three days (57.52-72.75%) (Table 4.3). The 
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high RSD values could possibly be due to the background levels of chloramphenicol. 
Repeatability precision for 7 samples fortified at the 0.5x level had RSDs ranging from 8-14%, 
with the exception of chloramphenicol which was 35% (Appendix Table 7.1).   




Accuracy Recovery, % 





Ciprofloxacin 2x 10 53.03 (32.46) 0.44 1.38 
 
1x 5 68.74 (30.53) 
  
 
0.5x 2.5 36.65 (25.06) 
  
      Enrofloxacin 2x 10 71.86 (4.29) 0.53 1.69 
 
1x 5 52.80 (19.53) 
  
 
0.5x 2.5 71.57 (31.12) 
  
      Sarafloxacin 2x 10 76.92 (2.68) 0.50 1.59 
 
1x 5 76.11 (6.34) 
  
 
0.5x 2.5 88.60 (12.39) 
  
      Florfenicol 2x 10 92.25 (14.02) 0.71 2.25 
 
1x 5 97.64 (25.20) 
  
 
0.5x 2.5 89.90 (10.52) 
  
      Chloramphenicol 2x 2 63.01 (72.75) 0.27 0.85 
 
1x 1 53.54 (59.56) 
   0.5x 0.5 40.98 (57.52)     
a Recoveries based on comparison to a single point matrix matched standard.  
b Method detection limit (MDL) = SD × 3.143, where SD is standard deviation from quantitative 
results of 0.5x spikes (n = 7) 
c LOQ= 10 x SD, where SD is standard deviation from quantitative results of 0.5x spikes (n=7) 
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4.2.4 MDL and LOQ 
MDL and LOQ were calculated from the standard deviation of residue concentrations in 
blank samples fortified at the 0.5x level. Detection and quantitation limits of the five veterinary 
drug residues are given in Table 4.3. The detection limits were between 0.27 and 0.71 ng/g, and 
the quantitation limits varied between 0.85 and 2.25 ng/g. The blank sample run with this data 
set had background levels of chloramphenicol near the 0.5x fortified levels, but was still less 
than each fortified sample. There was not enough blank crawfish left to run another 7 sample 
blanks to look at MDL of the blanks to determine if it was higher than the MDL for the 
fortification samples. The previous blanks that had been run were examined to calculate a MDL, 
which resulted in a similar value to what was previously obtained for the spiked samples. 
Therefore it was determined to use the MDL of the 0.5x fortified samples, since those were 
assumed to be more accurate as they had all been analyzed under the same conditions.  
4.3 Matrix Effects 
Matrix effects can impact quantitative analysis of compounds at trace levels. In order to 
determine whether the matrix was enhancing or suppressing the signal, standards at 50 and 10 
ng/mL prepared in solvent were compared to standards prepared with blank matrix, and showed 
general matrix enhancement. Other papers have reported matrix enhancement for ENR and CAP 
in catfish, and slight enhancement in frog legs43. Furthermore, another investigation found matrix 
enhancement for CIP in salmon, but suppressed in shrimp and tilapia52. Matrix enhancement in 
this investigation was further demonstrated by calculating recoveries of fortified samples using 
solvent standard curves and one-point matrix matched standards (Table 4.4). The high recoveries 
calculated when using solvent standard curves indicate matrix enhancement, with the exception 
of chloramphenicol which had similar recovery values. To minimize the matrix effect, recoveries 
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were calculated using matrix standards; it was also established that using a one-point matrix 
matched standard as opposed to a matrix matched standard curve provided slightly better results 
and was more efficient of resources and time.  
Table 4.4. Recoveries of 1x fortified samples using solvent standard curves and one-point matrix 
matched standards.  
Analyte 
Level of interest 
(1x) (ng/g) 
Solvent standard curve 
recovery, % (n=1) 
Matrix std-1 point 
recovery, % (n=3) 
Enrofloxacin 5 116.9 52.8 
Ciprofloxacin 5 228.5 68.7 
Sarafloxacin 5 280.9 76.1 
Florfenicol 5 163.5 97.6 
Chloramphenicol 1 50.2 53.5 
  
4.4 Targeted residues in retail samples 
This method was used to test two brands of Louisiana crawfish and two brands of 
Chinese crawfish, with three samples per brand tested. One Louisiana brand showed levels of 
chloramphenicol above the LOQ at an average concentration of 0.91 ng/g (Figure 4.1).   
 
Figure 4.1. Matrix matched standard (2.5 ng/mL) of chloramphenicol for Louisiana #1 (A), and 
positive sample result from Louisiana #1 sample 3 (B). 
 
A B 
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 One Chinese sample showed levels of chloramphenicol averaging 0.52 ng/g, which is above the 
MDL of 0.27 ng/g, but below the LOQ at 0.85 ng/g. This means it is statistically different from 
zero, but does not carry acceptable accuracy and precision and is not reliably quantifiable. No 
other veterinary drug residues were detected in any samples, as seen below in Table 4.5.  
Table 4.5. Concentration of veterinary drugs (ppb) in crawfish using LC/MS/MS.  
Origin Analyte 
MDL (LOQ) 
(ng/g) Concentrationa (ng/g) 
China  
   1 Chloramphenicol 0.27 (0.85) 0.52±0.20 
 
Florfenicol 0.71 (2.25) ND 
 
Enrofloxacin 0.53 (1.69) ND 
 
Ciprofloxacin 0.44 (1.38) ND 
 
Sarafloxacin 0.5 (1.59) ND 




















   1 Chloramphenicol 0.27 (0.85) 0.91±0.33 
 
Florfenicol 0.71 (2.25) ND 
 
Enrofloxacin 0.53 (1.69) ND 
 
Ciprofloxacin 0.44 (1.38) ND 
 
Sarafloxacin 0.5 (1.59) ND 















  Sarafloxacin 
 
ND 
a Reported as mean ± SD (n=3) 
b Adequate MS/MS spectra not obtained 
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 CHAPTER FIVE: SUMMARY AND CONCLUSIONS 5
 
The objective of this research was to expand upon past methods to validate a single 
method that could look at multiple veterinary drug residues in retail frozen crawfish. The use of 
unapproved veterinary drugs can lead to accumulation in crawfish tissue and also lead to 
antibiotic resistant bacteria that can then be passed onto the consumer. These can have 
deleterious effects on human health, especially with antibiotics such as chloramphenicol which 
can cause severe health consequences at dose-independent levels. Therefore, routine testing of 
multiple veterinary drug residues in food is important in order to protect public health.  
 The results of this investigation showed acceptable method performance characteristics 
when looking at selectivity, linearity, accuracy (recovery), precision (repeatability), limit of 
detection, and limit of quantitation. CIP demonstrated some of the lowest recoveries, though this 
was also found by others for frog legs using Q-TOF and LC-fluorescence43. One of the 
difficulties throughout method development was always having a background level of 
chloramphenicol and the inability to get a true blank. This made it impossible to obtain the level 
of interest at the MRPL of 0.3 ng/g. The lowest level standard tested was at 0.5 ng/g and this was 
just above the background levels for chloramphenicol. This background contamination could 
also have affected the precision, which had quite high RSD values for spike recovery at the three 
concentrations.  
The background contamination could be due to chloramphenicol occurring naturally in 
plant material, which is used as forage material and could be transferred to animal tissues50. It is 
known that the soil organism S. venezuelae and related organisms can biosynthesize CAP, and a 
few studies have quantified CAP in grasses and herbs50, cereal straw51, and soil—with this 
particular study showing that in a single day over 100 ug/kg of chloramphenicol can be produced 
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by S. venezuelae in nonsterile topsoil, a level that significantly exceeds the concentration 
calculated that could result in the detection of residues in crops19. The biology of the formation 
of CAP in arable soil is largely not understood51, though one study showed that CAP production 
and S. venezuelae growth rate are strongly related and depend on factors such as temperature and 
soil organic matter—with increased production after addition of carbon and nitrogen sources19.   
Analysis of retail samples showed two samples with elevated levels of chloramphenicol, 
and no other veterinary drug residues being detected. One sample from China showed levels of 
chloramphenicol averaging 0.52 ng/g, which is above the MDL of 0.27 ng/g, but below the LOQ 
of 0.85 ng/g. This means it is statistically different from zero, but does not carry acceptable 
accuracy and precision and is not reliably quantifiable. Another sample, this one being from 
Louisiana, showed a higher average level of chloramphenicol at 0.91 ng/g, which was above the 
LOQ and can thus be considered reliably quantifiable. However, it should be remembered that 
there were background levels of chloramphenicol in supposedly blank tissue, and with 
chloramphenicol potentially occurring naturally it is possible that products of animal origin can 
contain residues of CAP that are not due to illegal use of the drug50. 
Further testing is needed to investigate the safety of other imported crawfish that may be 
purchased by restaurants and not found in local grocery stores, including that from countries 
other than China. Other aquaculture species should also be examined to determine the extent of 
imported seafood contamination. Additionally, due to recent studies finding CAP occurring 
naturally in soil and crops, the occurrence in crops is probably more prevalent than we think and 
therefore soil and rice straw, which is the main forage material for crawfish, should be tested for 
chloramphenicol. A survey looking at different areas where crawfish are grown should be 
undertaken, including natural areas such as the Atchafalaya Basin. 
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 APPENDIX—SUPPLEMENTAL DATA 7





















CAP 0.133 0.198 0.148 0.300 0.251 0.303 0.360 48.35 35.33 
FF 1.366 1.729 1.931 1.658 1.843 1.789 2.077 70.824 12.697 
CIP 0.928 0.928 1.265 0.864 1.088 0.948 0.922 39.681 13.957 
ENR 1.423 1.750 1.207 1.434 1.347 1.318 1.467 56.830 11.914 
SARA 1.734 1.812 2.072 2.110 1.858 2.078 2.098 78.643 8.074 
 
Table 7.2. Matrix effects of standards at 50 and 10 ng/mL prepared in solvent vs. standards 
prepared with blank matrix. 
Analyte 
Concentration 
(ng/mL) Solvent Standard Area Matrix Standard Area 
Enrofloxacin 50 4807.79 16263.80 
 
10 450.74 3433.30 
    Ciprofloxacin 50 1376.704 4453.15 
 
10 264.302 754.37 
    Sarafloxacin 50 677.58 6166.19 
 
10 66.65 1240.90 
    Florfenicol 50 1617.67 2214.07 
 
10 266.70 357.36 
    Chloramphenicol 50 3084.95 2120.45 
 
















Figure 7.1. Matrix standard curves for florfenicol, ciprofloxacin, sarafloxacin (A); chloramphenicol (B); and enrofloxacin (C). 
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Figure 7.2. Solvent standard curves for florfenicol, sarafloxacin, and ciprofloxacin (A); chloramphenicol (B); and enrofloxacin (C). 




Figure 7.3. Chromatograms for matrix calibration standards of the three FQs and FF at 6.25 
ng/mL and CAP at 1.25 ng/mL. 




Figure 7.4. Chromatograms for fortification standards of the three FQs, FF, and CAP at the 0.5x 
level. 





Figure 7.5. Chromatograms of quantifier ion (151.91) and qualifier ion (256.89) of 
chloramphenicol showing the 0.5x matrix standard, matrix blank, and 0.5x fortified matrix (rep 
#1) from run to calculate MDL. 
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